Dr. Mohammad Askandar Iqbal

Associate Professor

Ph.D. in Biochemistry from Jawaharlal Nehru University in New Delhi, India

dr.askandar@gmu.ac.ae

Publications:

• Iqbal MA*, Smith K, Singh P, Siddiqui S, and Chandrasekaran S*, (2024) Protocol for Performing Metabolic Pathway-Based Subtyping of Breast Tumors, STAR Protocols Volume 5, Issue 3, 20 September 2024, 103173
• Iqbal MA*, Siddiqui S, Smith K, Singh P, Kumar B, Chouaib S, and Chandrasekaran S*, (2023) Metabolic stratification of human breast tumors reveal subtypes of clinical and therapeutic relevance, iScience, 26(10): 108059.
• Iqbal MA*, Siddiqui S, Rehman AU, Siddiqui FA, Singh P, Kumar B and Saluja D (2021). Multiomics integrative analysis reveals antagonistic roles of CBX2 and CBX7 in metabolic reprogramming in breast cancer. Molecular Oncology 15(5): 1450–1465.
• Iqbal MA*, Chattopadhyay S, Siddiqui FA, Rehman AU, Siddiqui S, Prakasam G, Khan A, Sultana S and Bamezai RNK (2020). Silibinin induces metabolic crisis in triple negative breast cancer cells by targeting EGFR-Myc-TXNIP axis: potential therapeutic implications. FEBS J 288 (2) 471-485.
• Siddiqui FA, Gopinath P, Chattopadhyay S, Rehman AU, Padder RA, Ansari MA, Irshad R, Mangalhara K, Bamezai, R, Husain M, Ali SM and Iqbal MA*(2018). Curcumin suppresses Warburg effect in cancer cells by down-regulating pyruvate kinase M2 via mTOR-HIF1α inhibition. Scientific Reports, 8, 8323.